Spironolactone safe, effective option for women with hidradenitis suppurativaOctober 3, 2023Mixed TopicsDermatology
FDA issues letter regarding lebrikizumab review for atopic dermatitisOctober 2, 2023DermatologyImmunology
European Commission grants approval of ritlecitinib for severe alopecia areataSeptember 19, 2023DermatologyPediatrics
Company submits supplemental NDA for topical atopic dermatitis treatmentSeptember 12, 2023PediatricsDermatologyImmunology
FDA to step up oversight of cosmetics, assess ‘forever chemicals’August 31, 2023Mixed TopicsDermatologyNephrologyNeurologyOncology
Dupilumab gains off-label uses as clinicians turn to drug for more indicationsAugust 23, 2023DermatologyMixed TopicsPulmonologyPediatrics
